| Literature DB >> 33167979 |
Zhenhua Guo1, Kunpeng Li2, Songlin Qiao1, Xin-Xin Chen1, Ruiguang Deng1, Gaiping Zhang3,4,5.
Abstract
BACKGROUND: African swine fever (ASF) is the most important disease to the pigs and cause serious economic losses to the countries with large-scale swine production. Vaccines are recognized as the most useful tool to prevent and control ASF virus (ASFV) infection. Currently, the MGF505 and MGF360 gene-deleted ASFVs or combined with CD2v deletion were confirmed to be the most promising vaccine candidates. Thus, it is essential to develop a diagnosis method to discriminate wide-type strain from the vaccines used.Entities:
Keywords: African swine fever virus; Differential diagnosis; Duplex real-time PCR; Gene-deleted strains
Mesh:
Substances:
Year: 2020 PMID: 33167979 PMCID: PMC7654620 DOI: 10.1186/s12917-020-02639-2
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Fig. 1Sequence analysis and alignment of primers and probes in ASFVs. The nucleotides sequence of primers and probes are consistent among the genotype II reference ASFV strains. Compared with the genotype I reference strains, the forward primer and probe targeting B646L gene have one nucleotide mutation at A345G and T376G sites, respectively. The probe targeting MGF505-2R gene has one nucleotide mutation at T265C site
Fig. 2Specificity of the duplex TaqMan real-time PCR assay. Other porcine viruses and the standard recombinant plasmid (pUC57-B646L and pUC57-MGF505-2R) were used to test the specificity
Fig. 3Sensitivity of the duplex real-time PCR assay. Sensitivity of the duplex real-time PCR for B646L gene and MGF505-2R gene. a 1–9: 5.8 × 108–100 dilutions of pUC57-B646L plasmid. b 1–9: 3.0 × 108–100 dilutions of pUC57-MGF505-2R plasmid
Fig. 4Standard curves for the duplex TaqMan PCR assay. a Standard curve for B646L gene, y = − 3.149x + 36.146, R = 0.990. b Standard curve for MGF505-2R gene, y = − 3.223x + 37.042, R = 0.999
Primers and probes used for the duplex TaqMan Probe-based real-time RT-PCR
| Primer/Probe | Sequence (5′-3′) | Amplicon size (bp) |
|---|---|---|
| B646L-F1 | GGGTGCATGTCATTCATCCT | 100 |
| B646L-R1 | GTCATATCCGTTGCGAGGAA | |
| B646L-P1 | FAM-AGGATGCTCCGATTCAGGGCACGTCCCA-BHQ1 | |
| MGF505-2R-F1 | AGCTCTTGTTACTGTGGAAGG | 173 |
| MGF505-2R-R1 | AAAACGTTCTAAAGCGTGGC | |
| MGF505-2R-P1 | VIC-ACGCCGTCATAGGAGCCTTGCAGGGTGA-BHQ1 |
Reference strains used in this study
| No. | Strain name | Accession no. | Regions | Year |
|---|---|---|---|---|
| 1 | ASFV/pig/China/CAS19–01/2019 | MN172368 | China, Hubei | 2019 |
| 2 | ASFV Wuhan 2019–2 | MN393477 | China, Hubei | 2019 |
| 3 | Pig/HLJ/2018 | MK333180 | China, Heilongjiang | 2018 |
| 4 | China/2018/AnhuiXCGQ | MK128995 | China, Anhui | 2018 |
| 5 | DB/LN/2018 | MK333181 | China, Liangning | 2018 |
| 6 | Belgium 2018/1 | LR536725 | Belgium | 2018 |
| 7 | CzechRepublic 2017/1 | LR722600 | CzechRepublic | 2017 |
| 8 | Estonia 2014 | LS478113 | Estonia | 2014 |
| 9 | Georgia 2008/1 | MH910495 | Georgia | 2008 |
| 10 | Georgia 2007/1 | NC_044959 | Georgia | 2007 |
| 11 | 22,653/Ca/2014 | MN270980 | Italy | 2014 |
| 12 | 47/Ss/2008 | KX354450 | Italy | 2008 |
Repeatability of duplex TaqMan real-time PCR
| Plasmid | Copy number | Inter-coefficient of variation | Intra-coefficient of variation | ||||
|---|---|---|---|---|---|---|---|
| Ct mean | Ct SD | CV% | Ct mean | Ct SD | CV% | ||
pUC57- B646L | 5.8 × 107 | 13.50 | 0.23 | 1.7 | 13.19 | 0.29 | 2.2 |
| 5.8 × 106 | 16.79 | 0.29 | 1.7 | 16.56 | 0.35 | 2.1 | |
| 5.8 × 105 | 19.53 | 0.12 | 0.6 | 19.57 | 0.03 | 0.1 | |
| 5.8 × 104 | 22.64 | 0.08 | 0.3 | 22.35 | 0.24 | 1.1 | |
| 5.8 × 103 | 26.02 | 0.14 | 0.5 | 25.99 | 0.12 | 0.5 | |
| 5.8 × 102 | 28.31 | 0.27 | 1 | 28.81 | 0.38 | 1.3 | |
| 5.8 × 101 | 31.75 | 0.08 | 0.3 | 32.05 | 0.27 | 0.8 | |
pUC57- MGF505-2R | 3.0 × 107 | 12.62 | 0.14 | 1.1 | 12.62 | 0.23 | 1.9 |
| 3.0 × 106 | 15.61 | 0.21 | 1.3 | 15.79 | 0.35 | 2.2 | |
| 3.0 × 105 | 19.02 | 0.08 | 0.4 | 18.94 | 0.38 | 2 | |
| 3.0 × 104 | 21.85 | 0.26 | 1.2 | 21.78 | 0.18 | 0.8 | |
| 3.0 × 103 | 25.82 | 0.22 | 0.9 | 25.60 | 0.37 | 1.5 | |
| 3.0 × 102 | 28.46 | 0.21 | 0.7 | 28.51 | 0.54 | 1.9 | |
| 3.0 × 101 | 31.43 | 0.16 | 0.5 | 31.70 | 0.76 | 2.4 | |
Detection of clinical samples using the established duplex real-time PCR assay
| Sample no. | Duplex TaqMan PCR assay | VetMAX™ ASFV Detection Kit | Sample no. | Duplex TaqMan PCR assay | VetMAX™ ASFV Detection Kit |
|---|---|---|---|---|---|
| 1 | 27.27/27.81 | 27.41/− | 14 | 34.19/34.64 | 35.74/− |
| 2 | 19.58/19.44 | 20.7/− | 15 | 31.05/29.86 | 31.98/− |
| 3 | 17.87/17.42 | 18.4/− | 16 | 33.45/33.85 | 33.9/− |
| 4 | 18.97/18.4 | 19.42/− | 17 | 32.91/31.9 | 32.77/− |
| 5 | 14.32/13.02 | 15.24/− | 18 | 31.97/31.84 | 32.99/− |
| 6 | 16.21/14.87 | 16.38/− | 19 | 30.97/30.12 | 31.94/− |
| 7 | 16.87/17.46 | 17.61/− | 20 | 34.49/33.73 | 36.52/− |
| 8 | 27.66/27.11 | 27.72/− | 21 | 33.99/35.61 | 35.64/− |
| 9 | 26.37/26.51 | 26.72/− | 22 | 35.62/37.0 | 35.19/− |
| 10 | 19.05/18.56 | 19.81/− | 23 | 34.51/35.51 | 35.42/− |
| 11 | 18.23/17.49 | 18.78/− | 24 | 37.16/39.76 | 36.99/− |
| 12 | 31.68/30.82 | 31.85/− | 25 | 36.12/38.4 | undetermined |
| 13 | 34.67/34.3 | 32.65/− | 26 | 36.95/− | undetermined |
Note: “-” means no detection, “undetermined” means no signal。